{"id":29777,"date":"2017-02-07T11:34:22","date_gmt":"2017-02-07T10:34:22","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=29777"},"modified":"2017-02-07T11:41:25","modified_gmt":"2017-02-07T10:41:25","slug":"fiducia-nelle-imprese-allultimo-posto-settore-farmaceutico","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/fiducia-nelle-imprese-allultimo-posto-settore-farmaceutico\/","title":{"rendered":"Trust in business. In last place is the pharmaceutical sector"},"content":{"rendered":"<p>Il Sole 24Ore reports the survey of the 17th edition of the Edelman Trust Barometer, the annual survey conducted in 28 countries on a sample of 33,000 people by the Edelman public relations agency.<\/p>\n<p>The investigation took place between October and November of last year. And therefore it was not affected by the effects of the hottest phase of the campaign of the constitutional referendum of 4 December.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" src=\"https:\/\/scontent-mxp1-1.xx.fbcdn.net\/v\/t1.0-9\/15940336_10155995674709848_2498113832026489109_n.jpg?oh=f294876ce50d0873b4eacaf02087dc05&amp;oe=59419885\" width=\"494\" height=\"183\" \/>Italy turns out to be the second country in Europe for trust in companies, even if that towards managing directors collapses. Confidence in the government remains at very low levels, albeit with a very slight recovery.<\/p>\n<p>The 78% of Italians believes that companies can carry out specific actions aimed not only at profit but also at the economic and social growth of the communities in which they operate and business is the category with the greatest confidence among Italians who are uncertain about the correct functioning of the system.<\/p>\n<p>Italians are also asking for stricter controls for companies: <strong>the 90% of the champion, for example, asks for more regulations for the pharmaceutical industry<\/strong> and 70% disagrees that financial market reforms have increased economic stability.<\/p>\n<p>The financial sector is recovering and, with a level of 40%, it no longer occupies the last position this year (but only in Italy because in the world average it is still financial services that rank <strong>in last place) the prerogative of the pharmaceutical sector <\/strong><\/p>\n<p>Article on <a href=\"http:\/\/www.ilsole24ore.com\/art\/notizie\/2017-02-06\/italia-secondo-posto-europa-la-fiducia-imprese-174438.shtml?uuid=AE9RWMP\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Sole 24ORE del\u00a0<\/span><\/a><time><span style=\"color: #0000ff;\">February 6, 2017<\/span> - Of\u00a0<\/time><strong><a href=\"http:\/\/argomenti.ilsole24ore.com\/andrea-marini.html\" target=\"_blank\" rel=\"author noopener\">Andrew Marini<\/a><\/strong><\/p>\n<p>Related news:\u00a0<a href=\"https:\/\/www.edelman.it\/wp-content\/uploads\/2016\/03\/EdelmaNews-Speciale-Trust-Barometer-2016.pdf\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Trust Barometer Edelman 2016: Trust is growing, especially in companies<\/span><\/a><\/p>\n<p><a href=\"http:\/\/www.edelman.com\/global-results\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">2017 Edelman Trust Barometer<\/span><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"\" src=\"https:\/\/image.slidesharecdn.com\/2017trustbarometerglobalreportfinalwotalktrack-170115180740\/95\/2017-edelman-trust-barometer-global-results-40-1024.jpg?cb=1485020243\" width=\"636\" height=\"358\" \/><\/p>","protected":false},"excerpt":{"rendered":"<p>Il Sole 24Ore riporta l&#8217;indagine della 17ma edizione dell&#8217;Edelman Trust Barometer, l&#8217;indagine annuale condotta in 28 paesi su un campione di 33mila persone dall&#8217;agenzia di relazioni pubbliche Edelman. L&#8217;indagine si \u00e8 svolta a cavallo tra l&#8217;ottobre e il novembre dell&#8217;anno scorso. E quindi non ha risentito degli effetti della fase pi\u00f9 calda della campagna del &hellip;<\/p>","protected":false},"author":4,"featured_media":5897,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[47],"class_list":["post-29777","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-big-pharma"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/29777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=29777"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/29777\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5897"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=29777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=29777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=29777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}